Johnson & Johnson
- Covid-19 News
Low demand, supply surplus leads J&J to suspend sales forecast of Covid vaccine
Pharmaceutical giant Johnson & Johnson says it’s currently unable to provide a sales forecast for its Covid-19 vaccine. According to the firm, vaccine hesitancy in low-income countries, coupled with existing low demand in wealthier nations, has led to a surplus of stock. J&J had previously forecast sales of up to US$3.5 billion for this year, according to a Reuters report.…
- Covid-19 News
Study finds Johnson & Johnson booster 85% effective against severe Omicron
A South African study has found that a booster dose of the Johnson & Johnson vaccine is 85% effective at preventing hospitalisation from the Omicron variant. According to an AFP report, researchers compared 69,000 healthcare workers who’d been given 2 doses of the vaccine, versus a group of unvaccinated people. The findings show that when a booster is administered between…
- World News
Amid growing vaccine hesitancy, South Africa asks Pfizer, J&J to suspend deliveries
While many countries around the world struggle to get enough Covid-19 vaccines for their people, South Africa is trying to avoid a stockpile. Growing vaccine hesitancy means the South African government has had to ask manufacturers such as Pfizer and Johnson & Johnson not to send any more shipments. This despite the country heading into a potential fourth wave of…
- Covid-19 News
FDA warns against smuggled Johnson & Johnson vaccines
In Sa Kaeo province in Eastern Thailand, the Food and Drug Administration is warning people to avoid offers of Johnson & Johnson vaccines that were illegally smuggled into Thailand after a patient apparently brought in a vaccine to a private clinic and paid to have medical staff administer it. The single-dose Johnson & Johnson vaccine has been approved for use…
- Covid-19 News
Chulabhorn Royal Academy rolls out booster vaccines
Booster shot registration has begun for Chulabhorn Royal Academy as they prepare to launch their drive to give third vaccines on October 20. The first round will be for those who received 2 injections of Sinovac and the second round will be for AstraZeneca vaccine recipients. Moderna and Sinopharm booster shots will commence 9 days later for special organisations and…
- Covid-19 News
Thai government signs contract for 20 million Pfizer doses
The government has approved the order of 20 million doses of the Covid-19 vaccine from US manufacturer, Pfizer. The Bangkok Post reports that the head of the Department of Disease Control signed the contract yesterday. Delivery will be some time this year, but when exactly is unclear, as the vaccine has yet to be approved by Thailand’s Food and Drug…
- Covid-19 News
Thailand to get 20 million doses of Pfizer vaccine, 5 million Johnson & Johnson doses
The Thai government is ordering 20 million doses of the Pfizer Covid-19 vaccine, along with 5 million of the Johnson & Johnson single-dose vaccine. Thai PBS World reports that deliveries are expected in the second half of the year. The Public Health Minister, Anutin Charnvirakul, and Nattaphon Narkpanich, chair of the Centre for Covid-19 Situation Administration, says the Pfizer and…
- Covid-19 News
25 million Pfizer and J&J vaccines coming, millions ready now
Thailand’s goal of giving 100 million vaccine shots by the end of 2021 may be met with the help of Pfizer and Johnson & Johnson, as negotiations for 25 million vaccines are ongoing now. PM Prayut Chan-o-cha had set a goal of 100 million vaccines and later increasing it to 150 million jabs, but so far only 6 million Sinovac…
- Covid-19 News
Doctor urges Pfizer, Moderna vaccine to fight B.1.351 variant
Reacting to the news that the B.1.351 variant of Covid-19 (commonly nicknamed the South African variant) has now been found in Thailand, a senior doctor at the Siriraj Centre of Research Excellence Management has called upon the government to obtain Pfizer, Moderna, and Johnson & Johnson vaccine as quickly as possible. In a Facebook post yesterday, the doctor suggested that…
- Covid-19 News
Johnson & Johnson Covid-19 vaccine re-approved in the US
The pause on the Johnson & Johnson Covid-19 vaccine was officially lifted in the US yesterday by the Centre For Disease Control And Prevention and the US Food And Drug Administration. They will add a warning label about the risk of blood clots, but vaccination can resume today. The CDC’s Advisory Committee For Immunization Practices recommended unpausing the Johnson &…
- Covid-19 News
US pauses use of Johnson & Johnson vaccine after “rare and severe” blood clots
Health officials in the United States have decided to pause administration of the Johnson & Johnson Covid-19 vaccine while they investigate a number of cases of “rare and severe” blood clots. According to a CNN report, a 45 year old woman has died and another patient is in critical condition. In total, there were 6 blood clot incidents, out of…
- Covid-19 News
Private hospitals in Thailand to get 10 million Covid-19 vaccine doses
In addition to the 70 million Covid-19 vaccine doses reserved by the government, private hospitals in Thailand can acquire another 10 million doses. The additional vaccines are needed to reach herd immunity against the coronavirus. Both the AstraZeneca and Sinovac vaccines, currently used for the government’s vaccination campaign, require 2 doses to be effective. The 70 million doses procured by…
- Covid-19 News
Survey shows growing acceptance of Covid-19 vaccines in some countries
A survey of 6 countries shows that the number of people willing to be vaccinated against Covid-19 is on the rise. The poll, conducted by the international consultancy KekstCNC, indicates that the number of people willing to be vaccinated has risen since last year. The countries that took part were the US, the UK, France, Germany, Japan, and Sweden, with…
- Covid-19 News
South Africa stalls AstraZeneca vaccine campaign after trial found “minimal protection” against new strain
South Africa’s rollout of AstraZeneca’s Covid-19 vaccine has been put on pause following reports that it only provides “minimal protection” for the new strain of the virus first detected in South Africa. The country will continue plans to administer the Pfizer-BioNTech vaccine and the Johnson & Johnson vaccine. The AstraZeneca vaccine, developed in partnership with Oxford University, only provides limited…
- Covid-19 News
Johnson & Johnson applies for vaccine registration in Thailand
The Food and Drug Administration has confirmed that multinational Johnson & Johnson has begun the process of registering its single-dose vaccine in Thailand. However, Surachoke Tangwiwat from the FDA adds that some required paperwork is still missing and will need to be filed within 30 days. Meanwhile, the FDA has begun checking the documentation that has been submitted. Surachoke adds…
- Covid-19 News
2 Covid vaccine trials halted in phase 3 over safety concerns
After Johnson & Johnson paused phase 3 of its Covid vaccine trials due to safety concerns, a second pharmaceutical company has followed suit. Eli Lilly has halted phase 3 trials of a lab-produced antibody treatment, 24 hours after the Johnson & Johnson decision. The Bangkok Post reports that an unspecified incident led Eli Lilly to call a temporary halt to…
